Pharmacokinetics and Pharmacodynamics of Febuxostat, a New Non-purine Selective Inhibitor of Xanthine Oxidase in Subjects with Renal Impairment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and Pharmacodynamics of Febuxostat, a New Non-purine Selective Inhibitor of Xanthine Oxidase in Subjects with Renal Impairment

Published:2005-01 Issue:1 Volume:12 Page:22-34
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:American Journal of Therapeutics

Author:

Mayer Michael D.,Khosravan Reza,Vernillet Laurent,Wu Jing-Tao,Joseph-Ridge Nancy,Mulford Darcy J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference12 articles.

1. The association between gout and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988-1994

2. The Management of Gout

3. An Extremely Potent Inhibitor of Xanthine Oxidoreductase

4. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents

5. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rare case of thrombocytopenia secondary to taking febuxostat;Italian Journal of Medicine;2024-04-23

2. Emergencies;Tata Memorial Centre Textbook of Oncology;2024

3. Important Considerations in the Intensive Care Management of Acute Leukemias;Journal of Intensive Care Medicine;2023-11-21

4. A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia;The Journal of Clinical Pharmacology;2022-10-20

5. Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report;Journal of Clinical Medicine;2022-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3